5-MAPBT
Clinical data | |
---|---|
Other names | MY400[1] |
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
Chemical and physical data | |
Formula | C12H15NS |
Molar mass | 205.32 g·mol−1 |
3D model (JSmol) | |
| |
|
5-MAPBT (5-methylaminopropylbenzothiophene) is an empathogenic drug closely related to 5-MAPB but with the oxygen atom replaced by sulfur, changing the core ring structure to benzothiophene rather than benzofuran.[2]
See also
References
- ^ Mydecine (5 January 2024). "Novel short-acting psychoactive compounds of the mdma class". Google Patents. Retrieved 23 October 2024.
- ^ WO 2022/010937, Baggott M, "Advantageous benzothiophene compositions for mental disorders or enhancement.", published 13 January 2022, assigned to Tactogen Inc.